1-2 of 2
Laurens Nieuwenhuizen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Harnessing Cell-Free DNA Biological Features for Early Treatment Response Prediction in High Grade B-Cell Lymphoma

Ymke van der Pol, Steven Wang, Norbert Moldovan, A.Vera de Jonge, Esther E.E. Drees, Margaretha Roemer, Bauke Ylstra, Marcel Nijland, Marjolein W.M. Van Der Poel, Koen de Heer, Clara Klerk, Rozemarijn van Rijn, Rob Fijnheer, Vibeke K.J. Vergote, Aart Beeker, Laurens Nieuwenhuizen, Rogier Mous, Joost S.P. Vermaat, D. Michiel Pegtel, Martine E.D. Chamuleau, Florent Mouliere
Journal: Blood
Blood (2022) 140 (Supplement 1): 3529–3531.
https://doi.org/10.1182/blood-2022-168668
Published: 2022